您的搜索操作未匹配到任何结果。
我们建议您尝试以下操作，以帮助您找到所需内容：
Nanjing, China—November 12, 2019
Nanjing CR Medicon Pharmaceutical Technology CO., Ltd., a Gold level member of Oracle PartnerNetwork (OPN) is collaborating with Oracle Health Sciences to expand their current clinical development offerings with drug safety surveillance and pharmacovigilance services from Oracle Argus. CR Medicon is a subsidiary of Pharmaron, a China-based Clinical Research Organization.
Oracle Argus is an industry-leading solution for safety case management, used to process, analyze, and report adverse event cases originating in pre- and post-market drugs, biologics, vaccines, devices, and combination products.
With China’s global alignment on clinical development and new regulations on drug safety by the National Medical Products Administration (NMPA), National Medical Products Administration (CDE) and the National Center for Adverse Drug Reactions (ADR) Monitoring, local and global pharmaceutical companies doing business in China are in need of a reliable drug safety database that is designed to help meet both international and local regulatory requirements. The collaboration of Oracle Health Sciences and CR Medicon brings the Argus technology together with CR Medicon’s expertise in pharmacovigilance management to provide a one-stop solution for pharmaceutical and biotech organisations seeking to maintain regulatory compliance, while improving their pharmacovigilance practices.
“By combining Oracle Health Science’s Argus safety platform with CR Medicon’s in-depth knowledge in pharmacovigilance, we are positioned to support the rapid growth of clinical trials in China and the compliance requirements that surround them,” said Mr. Henry Wu, CEO, CR Medicon. “In addition, with Oracle’s extensive Oracle PartnerNetwork program, we are very confident that our work with Oracle can maximize the confidence of a growing number of sponsors who demand highly skilled and trained pharmacovigilance professionals and services all optimized on best in class technology.”
Through this collaboration, CR Medicon will help its clients to better optimize global compliance and integrate risk management into key processes and regulatory submission, so local and global sponsors can leverage these services and the Argus platform to help meet their safety and compliance requirements.
“CR Medicon has top-notch drug safety surveillance and pharmacovigilance professionals who can help pharmaceutical and biotech organisations leverage the power of Argus to support product safety monitoring and compliance with local and global regulatory requirements,” said Mr. Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Together, CR Medicon’s professional services and Oracle’s comprehensive pharmacovigilance platform will deliver to pharmaceuticals what they need to help effectively manage product safety.”
(CR Medicon, http://www.crmedicon.com), is a China-based clinical CRO company (a subsidiary of Pharmaron - a global leading life science services company) that provides comprehensive clinical development services, including regulatory, medical strategy, medical writing, clinical operations, data management & statistical analysis, bioanalytical laboratory, as well as pharmacovigilance solutions for both domestic and overseas companies.
Oracle Health Sciences breaks down barriers and opens new pathways to unify people and processes to bring new drugs to market faster. As a leader in Life Sciences technology, Oracle Health Sciences is trusted by 30 of the top 30 pharma, 10 of the top 10 biotech and 10 of the top 10 CROs for managing clinical trials and pharmacovigilance around the globe.
Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise and proven success. To find out more visit http://www.oracle.com/partners.
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
注：为免疑义，本网页所用以下术语专指以下含义：